LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Normalized Growth Rate Inhibition Value Standard Error of the Mean for Normalized Growth Rate Inhibition Value
MCF7 GSK1904529A
0.37
uM
LJP6
0.5311 0.0238 0.4044 0.0534
MCF7 GSK1904529A
1.11
uM
LJP6
0.5030 0.0176 0.3631 0.0465
MCF7 GSK1904529A
3.33
uM
LJP6
0.4994 0.0118 0.3580 0.0397
MCF7 GSK1904529A
10
uM
LJP6
0.4745 0.0227 0.3192 0.0527
MCF7 Linsitinib
0.04
uM
LJP5
0.7542 0.0152 0.7214 0.0082
MCF7 Linsitinib
0.12
uM
LJP5
0.7824 0.0483 0.7488 0.0663
MCF7 Linsitinib
0.37
uM
LJP5
0.6325 0.0733 0.5548 0.1094
MCF7 Linsitinib
1.11
uM
LJP5
0.5504 0.0434 0.4494 0.0809
MCF7 Linsitinib
3.33
uM
LJP5
0.5015 0.0215 0.3834 0.0524
MCF7 Linsitinib
10
uM
LJP5
0.4269 0.0176 0.2706 0.0515
MCF7 Ruxolitinib
0.04
uM
LJP5
0.9717 0.0329 0.9671 0.0360
MCF7 Ruxolitinib
0.12
uM
LJP5
0.9503 0.0255 0.9477 0.0272
MCF7 Ruxolitinib
0.37
uM
LJP5
0.9658 0.0212 0.9627 0.0245
MCF7 Ruxolitinib
1.11
uM
LJP5
1.0500 0.0213 1.0503 0.0220
MCF7 Ruxolitinib
3.33
uM
LJP5
1.0498 0.0137 1.0520 0.0156
MCF7 Ruxolitinib
10
uM
LJP5
0.8040 0.0297 0.7775 0.0431
MCF7 Momelotinib
0.04
uM
LJP5
0.9209 0.0094 0.9123 0.0139
MCF7 Momelotinib
0.12
uM
LJP5
0.9081 0.0471 0.8957 0.0568
MCF7 Momelotinib
0.37
uM
LJP5
0.8501 0.0411 0.8304 0.0533
MCF7 Momelotinib
1.11
uM
LJP5
0.6816 0.0258 0.6276 0.0481
MCF7 Momelotinib
3.33
uM
LJP5
0.4731 0.0612 0.3323 0.1137
MCF7 Momelotinib
10
uM
LJP5
0.3055 0.0134 0.0654 0.0224
MCF7 Fedratinib
0.04
uM
LJP5
1.0201 0.0322 1.0189 0.0345
MCF7 Fedratinib
0.12
uM
LJP5
0.9672 0.0397 0.9602 0.0455
MCF7 Fedratinib
0.37
uM
LJP5
0.8367 0.0478 0.8126 0.0612